| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Apr―28 |
Changes in first-episode psychosis care delivery and outcomes throughout the COVID-19 pandemic: Insights from a learning healthcare system in Massachusetts |
Ananya Saluja, Kelsey A. Johnson, Dost Öngür, Margaret Lanca, Lynn E. DeLisi, Raquelle I. Mesholam-Gately, Margaret E. Guyer, Matcheri S. Keshavan |
| 2 |
[GO] |
2025―Feb―04 |
COVID-19 outbreak in a ward led three patients to discontinue clozapine due to neutropenia: Call for urgent considerations regarding clozapine regulation in Japan |
Yuki Kikuchi, Sota Ueno, Bunichiro Onodera, Hiroaki Tanifuji, Hiroshi Komatsu, Hiroaki Tomita |
| 3 |
[GO] |
2025―Jan―08 |
Justice delayed? Wait times and behavioral emergencies in involuntary psychiatric treatment before and after COVID-19: A 3-year retrospective study |
Reuben Heyman-Kantor, Minnie Horvath Laury, Esther Schoenfeld, Cara Angelotta, Ann Kan, Kwang-Youn A. Kim, Richard G. Cockerill |
| 4 |
[GO] |
2024―Sep―14 |
Recognition of schizophrenia and quality of treatment during the COVID-19 pandemic: A Danish nationwide study |
Simon Ploug Gartner, Tina Bech Olesen, Henry Jensen, Lotte Maxild Mortensen, Lone Baandrup |
| 5 |
[GO] |
2024―Aug―28 |
What impact did the COVID-19 pandemic have on psychosis and the delivery of early intervention psychosis services? |
Sorcha J. Cotter, Catherine L. Smith, Caroline X. Gao, Rahul Khanna, Brian O'Donoghue, Ellie Brown, Andrew Thompson |
| 6 |
[GO] |
2024―Aug―27 |
The impact of COVID-19 public health measures on the utilization of antipsychotics in schizophrenia in Manitoba - A population-based study |
Mina Shirinbakhshmasoleh, Laila Aboulatta, Christine Leong, Hayley Riel, Kun Liu, Joseph C. Delaney, James M. Bolton, Jamison Falk, Silvia Alessi-Severini, Sherif Eltonsy, Kaarina Kowalec |
| 7 |
[GO] |
2024―Aug―01 |
Evaluating the impact of COVID-19 on medication adherence and health care utilization among individuals with psychotic disorders who are prescribed long-acting injectables (LAIs) or clozapine: A population-based study in Manitoba, Canada |
Yushi W. MacMillan-Wang, Jennifer M. Hensel, Christine Leong, Rajat Jayas, Eunice Valencia, Arianna Yorski, Kun Liu |
| 8 |
[GO] |
2024―Jul―20 |
Increased COVID-19 mortality in patients with schizophrenia: A retrospective study in Brazil |
Diogo Fernando Bornancin Costa, Paula Rossignoli, Deise Regina Sprada Pontarolli, Paulo Collodel Junior, Camilla Luz Assolari, Acácia Maria Lourenço Francisco Nasr, Denise Siqueira de Carvalho, Ary Gadelha, Raffael Massuda |
| 9 |
[GO] |
2024―Jul―13 |
Feasibility and Acceptability of a Physical Activity Group Program Using telerehabilitation during the COVID-19 Pandemic in Multiple early Intervention for Psychosis Services |
Maria Thibault, Ahmed Jérôme Romain, Charles Tessier, Jean Manneville Jr. Theagene, Valérie Chauvin, Amal Abdel-Baki |
| 10 |
[GO] |
2024―Apr―10 |
COVID-19 pandemic and emergency department visits for psychosis: Visit volume, restraint use, medication use, psychiatric hospitalization, and length of stay |
Brittany M. Gouse, Rachel Oblath, Jada S. Gibbs, Ellen G. Reagan, Hannah E. Brown |
| 11 |
[GO] |
2024―Mar―25 |
Association between discrimination and subsequent psychotic experiences in patients with COVID-19: A cohort study |
Zui Narita, Megumi Hazumi, Mayumi Kataoka, Kentaro Usuda, Daisuke Nishi |
| 12 |
[GO] |
2024―Feb―19 |
Tardive dyskinesia's under-recognition in the era of COVID-19 |
Derek Zhang, Samuel Law, Saadia Sediqzadah |
| 13 |
[GO] |
2023―Nov―14 |
Longitudinal observations of the severity of COVID-19 infection and its impact on clozapine/norclozapine levels and clozapine toxicity in patients experiencing multiple episodes |
Kimberly Clinebell, Jane Thomas, Melanie Yabs, K.N. Roy Chengappa |
| 14 |
[GO] |
2023―Sep―15 |
Letter to the editor: Clozapine plasma levels under co-medication with fluvoxamine during COVID-19 infection: A case report |
Maxim Kuzin, Carla Boeglin, Georgios Schoretsanitis, Manjinder Pannu, Wolfram Kawohl, Franziskos Xepapadakos |
| 15 |
[GO] |
2023―Sep―08 |
COVID-19 vaccination among patients with schizophrenia prescribed clozapine |
Yachana Panchal, Jessica M. Gannon, Janina-Marie Tatar, G.K. Balasubramani |
| 16 |
[GO] |
2023―Aug―23 |
Psychotic experiences, perceived stress, and suicidal ideation among the general population during the COVID-19 pandemic: Findings from Japan |
Andrew Stickley, Aya Shirama, Tomiki Sumiyoshi |
| 17 |
[GO] |
2023―Jul―14 |
Increasing disparities in cancer screening among people with severe mental illness during the COVID-19 pandemic |
Masaki Fujiwara, Yuto Yamada, Taichi Shimazu, Naoki Nakaya, Shiro Hinotsu, Maiko Fujimori, Yosuke Uchitomi, Masatoshi Inagaki |
| 18 |
[GO] |
2023―Mar―28 |
Potential mechanisms between psychotic-like experiences and suicidal ideation in the context of COVID-19: A longitudinal study |
Yue Li, Liang Zhou, Dongfang Wang, Ling Jing, Meng Sun |
| 19 |
[GO] |
2023―Mar―09 |
Memantine treats psychosis and agitation associated with Moderna COVID-19 vaccine |
Wen-Huei Siao, Fang-Yu Chang, Yi-Chyan Chen |
| 20 |
[GO] |
2023―Feb―10 |
Schizophrenia and COVID-19: A bibliometric analysis of trends and themes |
Suraj Kushe Shekhar |
| 21 |
[GO] |
2023―Jan―23 |
Psychotic-like experiences during COVID-19 lockdown among adolescents: Prevalence, risk and protective factors |
Dongfang Wang, Liang Zhou, Chunping Chen, Meng Sun |
| 22 |
[GO] |
2023―Jan―20 |
Epidemiology of infection, transmission and COVID-19 outcomes among mental health users and workers in a comprehensive network of long-term mental health facilities: Retrospective observational population-base study |
Manuel Canal-Rivero, Javier Vázquez-Hernández, Marta León-Gómez, Silvia Maraver-Ayala, Luis Fernández-Portes, Soraya Sánhez-Benítez, Nathalia Garrido-Torres, Miguel Ruiz-Veguilla, Benedicto Crespo-Facorro |
| 23 |
[GO] |
2023―Jan―03 |
Prevalence of psychological reactions and suicidal ideation during one year of the COVID-19 pandemic in patients with severe mental disorders |
Leticia González-Blanco, Pilar A. Sáiz, Francesco Dal Santo, Leticia García-Álvarez, Luis Jiménez-Treviño, Gonzalo Paniagua, María Teresa Bobes-Bascarán, María Paz García-Portilla, Julio Bobes |
| 24 |
[GO] |
2022―Oct―12 |
A profile of high scores on the Peters delusion inventory and low engagement in pandemic-related health behaviors in a non-clinical sample |
Michael Joseph Minzenberg, Jong H. Yoon |
| 25 |
[GO] |
2022―Jun―27 |
Worsening of psychotic experiences in college students during the COVID-19 pandemic |
J. Zimmerman, N.R. DeTore, W. Deng, A. Burke, M. Nyer, D.J. Holt |
| 26 |
[GO] |
2022―Jun―06 |
A call to action: Increased mortality from COVID-19 among individuals with schizophrenia calls for coordinated vaccination efforts |
Shayna H. Schor, Jada S. Gibbs, Brittany M. Gouse, Hannah E. Brown |
| 27 |
[GO] |
2022―May―19 |
COVID-19 infection, fluctuations in the clozapine/norclozapine levels and metabolic ratio and clozapine toxicity: An illustrative case-report |
K.N. Roy Chengappa, Jane Thomas, Charles E. Kahn, Kimberly Clinebell, Kelly K. Mullen, Lori Arbutiski, Emil Ivanov |
| 28 |
[GO] |
2022―Mar―04 |
COVID-19 contamination and severity among patients with schizophrenia: Results from a specialized outpatient clinic survey |
Carlos Gustavo Costardi, Fernando Malinowski, Lais Fonseca, Luciene Redondo, Cristiano Noto, Ary Gadelha |
| 29 |
[GO] |
2022―Feb―26 |
Negative schizotypy attenuates the effect of momentary stress on social dysfunction related to COVID-19 social distancing |
Michael D. Masucci, Victoria Martin, Thanh P. Le, Alex S. Cohen |
| 30 |
[GO] |
2022―Feb―17 |
Adaptive and maladaptive consequences of increased social media and internet use during the COVID-19 pandemic in schizophrenia |
Luyu Zhang, Gregory P. Strauss |
| 31 |
[GO] |
2022―Feb―01 |
Pandemic paranoia, general paranoia, and their relationships with worry and beliefs about self/others - A multi-site latent class analysis |
Suzanne Ho-wai So, Chen Zhu, Tania M. Lincoln, Brandon A. Gaudiano, Jessica L. Kingston, Lyn Ellett, Eric M.J. Morris |
| 32 |
[GO] |
2022―Jan―24 |
Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2? |
Cintia R. Prokopez, Romina Farinola, Miguel Vallejos, Lorena S. Lopredo, Luciano E. Sfriso, Luciana C. Chiapella, Claudio Arce, Ricardo M. Corral, Manuel J. Cuesta, Martín Alomo |
| 33 |
[GO] |
2022―Jan―24 |
First episode psychosis following receipt of first dose of COVID-19 vaccine: A case report |
Sandeep Grover, Seema Rani, Komal Kohat, Sanjana Kathiravan, Garima Patel, Swapnajeet Sahoo, Aseem Mehra, Shubhmohan Singh, Sanjay Bhadada |
| 34 |
[GO] |
2022―Jan―10 |
Clozapine toxicity and coronavirus disease 2019: A case report |
Maria Sagué-Vilavella, Hugo López-Pelayo, Néstor Arbelo, Mercè Cámara, Susana Gomes, Santiago Madero, Maria Teresa Pons-Cabrera, Luis Pintor |
| 35 |
[GO] |
2022―Jan―05 |
Correlates of Psychotic Like Experiences (PLEs) During Pandemic: An Online Study Investigating a Possible Link Between the SARS-CoV-2 Infection and PLEs Among Adolescents |
Helin Yilmaz Kafali, Serkan Turan, Serap Akpınar, Müge Mutlu, Aslınur Özkaya Parlakay, Esra Çöp, Timothea Toulopoulou |
| 36 |
[GO] |
2021―Dec―22 |
An overall protective effect of antipsychotic drugs against COVID-19 seems implausible |
Ángel Ruiz de Pellón-Santamaría, Cristina Sarasqueta-Eizaguirre, Francisco Javier Basterrechea-Peña |
| 37 |
[GO] |
2021―Sep―16 |
Psychotic behaviors during COVID-19: Should conspiracist ideation be included within the continuum model of psychosis? |
Álex Escolà-Gascón, Abigail C. Wright |
| 38 |
[GO] |
2021―Sep―14 |
COVID-19 dimensions and psychotic experiences among US college students: Findings from the Healthy Mind Study 2020 |
Hans Oh, Jessica Goehring, Ravi Rajkumar, Megan Besecker, Sasha Zhou, Jordan E. DeVylder |
| 39 |
[GO] |
2021―Sep―01 |
H1N109 pandemic research in people with schizophrenia providing insights into COVID-19 clinical care |
Paul A. Maguire, Rebecca E. Reay, Jeffrey C.L. Looi |
| 40 |
[GO] |
2021―Sep―01 |
Mediating role of metacognitive beliefs and cognitive-attentional syndrome in the relationship between persecutory and coronavirus conspiracy beliefs in a community sample |
Joachim Kowalski, Łukasz Gawęda |
| 41 |
[GO] |
2021―Sep―01 |
Changes of psychotic-like experiences and their association with anxiety/depression among young adolescents before COVID-19 and after the lockdown in China |
Zhipeng Wu, Zhening Liu, Zhulin Zou, Feiwen Wang, Mengran Zhu, Wen Zhang, Haojuan Tao, Brendan Ross, Yicheng Long |
| 42 |
[GO] |
2021―Aug―07 |
Incidence and outcome of COVID-19 in patients with schizophrenia: A Study from India |
Sandeep Grover, Sanjana Kathiravan, Aarzoo Suman, Chandrima Naskar, Aseem Mehra, Swapnajeet Sahoo, Subho Chakrabarti |
| 43 |
[GO] |
2021―Jul―30 |
Adherence to recommended health and social distancing precautions during the COVID-19 pandemic in individuals with schizophrenia and youth at clinical high-risk for psychosis |
Kelsey I. Macdonald, Michael J. Spilka, Lisa A. Bartolomeo, Ian M. Raugh, Alysia M. Berglund, Gregory P. Strauss |
| 44 |
[GO] |
2021―Jul―30 |
Can antipsychotic use protect from COVID-19? |
Luiz Dratcu, Xavier Boland |
| 45 |
[GO] |
2021―Jul―22 |
Starting clozapine in patients with schizophrenia during the ongoing pandemic |
Sandeep Grover, Chandrima Naskar, Swapnajeet Sahoo, Aseem Mehra, Subho Chakrabarti |
| 46 |
[GO] |
2021―Jul―14 |
The immediate impact of the COVID-19 pandemic on attenuated positive symptoms and functioning in individuals at clinical high risk for psychosis: A pilot study |
Ricardo E. Carrión, Andrea M. Auther, Danielle McLaughlin, Barbara A. Cornblatt |
| 47 |
[GO] |
2021―Jul―08 |
The role of antipsychotics against COVID-19: A topic for debate |
M. Canal-Rivero, R. Catalán-Barragán, A. Rubio-García, N. Garrido-Torres, B. Crespo-Facorro, M. Ruiz-Veguilla, C.M. García-Sánchez, V.E. Martín-Gil, A. Arias-Ruiz, M. Estévez-Martín |
| 48 |
[GO] |
2021―Jul―02 |
Sedentary behaviour in young people presenting with a first episode of psychosis before and during the covid-19 pandemic restrictions |
Brian O'Donoghue, Emily Castagnini, Alison Langstone, Nathan Mifsud, Andrew Thompson, Eoin Killackey, Patrick McGorry |
| 49 |
[GO] |
2021―Jun―26 |
Letter on: “Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population” |
Ahmad Amjed Toubasi |
| 50 |
[GO] |
2021―Jun―23 |
An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses |
Cintia R. Prokopez, Miguel Vallejos, Lorena S. Lopredo, Luciano E. Sfriso, Luciana C. Chiapella, Claudio Arce, Ricardo M. Corral, Manuel J. Cuesta, Romina Farinola, Martín Alomo |
| 51 |
[GO] |
2021―Jun―16 |
New variants and new symptoms in COVID-19: First episode psychosis and Cotard's Syndrome two months after infection with the B.1.1.7 variant of coronavirus |
Umit Haluk Yesilkaya, Meltem Sen, Nesrin Karamustafalioglu |
| 52 |
[GO] |
2021―Mar―14 |
Changes in psychotic-like experiences and related influential factors in technical secondary school and college students during COVID-19 |
Meng Sun, Dongfang Wang, Ling Jing, Liang Zhou |
| 53 |
[GO] |
2021―Feb―21 |
Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population |
M. Canal-Rivero, R. Catalán Barragán, A. Rubio García, N. Garrido Torres, B. Crespo-Facorro, M. Ruiz-Veguilla |
| 54 |
[GO] |
2021―Feb―21 |
Induced ideas of reference during social unrest and pandemic in Hong Kong |
Stephanie M.Y. Wong, Christy L.M. Hui, Corine S.M. Wong, Y.N. Suen, Sherry K.W. Chan, Edwin H.M. Lee, W.C. Chang, Gloria H.Y. Wong, Eric Y.H. Chen |
| 55 |
[GO] |
2021―Jan―18 |
Factors associated with mask wearing among psychiatric inpatients during the COVID-19 pandemic |
Ha-Ran Jung, Cheol Park, Mina Kim, Min Jhon, Ju-Wan Kim, Seunghyong Ryu, Ju-Yeon Lee, Jae-Min Kim, Kyung-Hwa Park, Sook-In Jung, Bo-Hyun Yoon, Sung-Wan Kim |
| 56 |
[GO] |
2020―Aug―06 |
The COVID pandemic and the endemic disparities in care across race for psychotic disorders |
Fabio Ferrarelli, Matcheri S. Keshavan |
| 57 |
[GO] |
2020―Jul―25 |
COVID-19 lockdown in people with severe mental disorders in Spain: Do they have a specific psychological reaction compared with other mental disorders and healthy controls? |
Leticia González-Blanco, Francesco Dal Santo, Leticia García-Álvarez, Lorena de la Fuente-Tomás, Carlota Moya Lacasa, Gonzalo Paniagua, Pilar A. Sáiz, María Paz García-Portilla, Julio Bobes |
| 58 |
[GO] |
2020―Jul―25 |
Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2? |
B. Nobile, M. Durand, P. Courtet, P. Van de Perre, N. Nagot, J.P. Molès, E. Olié |
| 59 |
[GO] |
2020―Jun―15 |
The DOSMD challenge and the COVID-19 conundrum |
Ravi Philip Rajkumar |
| 60 |
[GO] |
2020―Jun―15 |
Unmask the mind! Importance of video consultations in psychiatry during COVID-19 pandemic |
Jagadisha Thirthalli, Narayana Manjunatha, Suresh Bada Math |
| 61 |
[GO] |
2020―May―28 |
Telephonic monitoring of patients on clozapine in the resource-poor setting during the COVID-19 pandemic |
Sandeep Grover, Eepsita Mishra, Subho Chakrabarti, Aseem Mehra, Swapnajeet Sahoo |
| 62 |
[GO] |
2020―May―27 |
The impact of COVID-19 on individuals living with serious mental illness |
Kareem Hamada, Xiaoduo Fan |
| 63 |
[GO] |
2020―May―26 |
Ensuring care for clozapine-treated schizophrenia patients during the COVID-19 pandemic |
Jessica Nichols, Jessica M. Gannon, Judith Conlogue, Deepak Sarpal, Jamie L. Montgomery, Robin Sherwood, Tanya Fabian, Juliette R. Ballough, Noreen M. Fredrick, K.N. Roy Chengappa |
| 64 |
[GO] |
2020―May―16 |
The “mind” behind the “mask”: Assessing mental states and creating therapeutic alliance amidst COVID-19 |
Urvakhsh Meherwan Mehta, Ganesan Venkatasubramanian, Prabha S. Chandra |
| 65 |
[GO] |
2020―May―14 |
Clozapine treated patients and COVID-19: Ensuring continued care through collaboration |
Jonathan G. Leung, Terri S. Wittenberger, Kathryn M. Schak |
| 66 |
[GO] |
2020―May―13 |
Psychotic experiences in student population during the COVID-19 pandemic |
Michal Hajdúk, Daniel Dančík, Jakub Januška, Viktor Svetský, Alexandra Straková, Michal Turček, Barbora Vašečková, Ľubica Forgáčová, Anton Heretik, Ján Pečeňák |
| 67 |
[GO] |
2020―May―07 |
Long acting injectable antipsychotic medications: Ensuring care continuity during the COVID-19 pandemic restrictions |
Jessica M. Gannon, Judith Conlogue, Robin Sherwood, Jessica Nichols, Juliette R. Ballough, Noreen M. Fredrick, K.N. Roy Chengappa |
| 68 |
[GO] |
2020―May―06 |
The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research |
Ellie Brown, Richard Gray, Samantha Lo Monaco, Brian O'Donoghue, Barnaby Nelson, Andrew Thompson, Shona Francey, Pat McGorry |
| 69 |
[GO] |
2020―Apr―27 |
Long-acting injectable antipsychotics treatment during COVID-19 pandemic - A new challenge |
Petru Ifteni, Lorena Dima, Andreea Teodorescu |
| 70 |
[GO] |
2020―Apr―16 |
COVID-19, mobile health and serious mental illness |
John Torous, Matcheri Keshavan |
| 71 |
[GO] |
2020―Apr―04 |
Is schizophrenia research relevant during the COVID-19 pandemic? |
Henry R. Cowan |
